Theorem Clinical Research, the US-based provider of clinical research and development services, is tapping into the medical-imaging expertise increasingly required in clinical trials by adding imaging specialist RadMD to its roster of strategic alliances.
With headquarters in Doylestown, Pennsylvania and a global network of more than 600 physicians and medical-imaging experts, RadMD provides consultancy services for the development and implementation of medical-imaging strategies and endpoints in clinical studies.
Its capabilities include customised medical-imaging solutions, independent image evaluations or ‘blinded reads’, regulatory strategy, imaging-endpoint justification and specialist training.
RadMD offers unique services focused solely on the use of imaging in clinical trials and drawing on extensive experience in the pharmaceutical development of both diagnostics and therapeutics, Theorem pointed out.
“These kinds of alliances allow us to extend our capabilities to offer a greater depth and spectrum of services to our clients,” commented D. Lee Spurgin Jr., the company’s senior vice president and general manager of medical device and diagnostic development.
“When we work with partners that we already know and trust we feel our clients get a better end result,” Spurgin added.
Last month, Theorem boosted its resources in regulatory consulting and medical devices/diagnostics through a strategic partnership with Emergo Group.